Experian adds Medicaid income checks while Experian stock trades at EUR 33.10

Published on 10/15/2026 at 13:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Experian Health adds Medicaid income checks for providers. Experian stock costs EUR 33.10 on October 15, 2026, with 533,545 shares issued in September.

Healthcare expansion and share issuance

Experian Health announced Medicaid verification additions on October 13, 2026.
Experian issued 533,545 ordinary shares during September 2026.
Experian stock trades at EUR 33.10 at 1:15 p.m. CEST at Lang & Schwarz on October 15, 2026.

Analysten prüfen Finanzdaten und Bonitäts-Dashboards in modernem Rechenzentrum — Experian plc (ISIN IE00B19NLV48) analysiert Kreditdaten im modernen Rechenzentrum mit digitalen Auswertungen, Illustration mit AI erstellt.

Experian stock (ISIN GB00B19NLV48) was trading at EUR 33.10 at Lang & Schwarz on October 15, 2026, as the company expanded its healthcare verification tools. According to FinanzNachrichten on October 13, 2026, Experian Health announced income and employment verification inside its Patient Financial Clearance product.

Healthcare tools target January 2027

The addition is aimed at healthcare providers preparing for new Medicaid eligibility verification requirements taking effect on January 1, 2027. Experian Verify supplies income and employment information through automated workflows, allowing providers to assess eligibility and financial assistance options more quickly.

The product move gives Experian a concrete use case beyond traditional credit decisions. The company said its healthcare business serves more than 60 percent of U.S. hospitals and more than 5,800 medical practices, labs, pharmacies and other providers, according to the same October 13 announcement.

What changed across three dates?

Experian appointed BT executive Adam Crozier as chair-designate on April 21, 2026, according to Global Banking and Finance Review. On September 30, 2026, the company issued 533,545 ordinary shares, taking the total admitted to the London Stock Exchange Main Market to 938,871,403, according to Investegate. The healthcare announcement followed on October 13, 2026.

Which dates matter next?

The next dated operating milestone is January 1, 2027, when the new Medicaid verification requirements take effect. That date matters because Experian's product is designed to help providers meet the documentation and screening demands linked to the rules.

Stock context stays currency-sensitive

Experian's primary listing is on the London Stock Exchange, where the stock was last quoted at GBp 2,791 at 12:23 p.m. BST on October 15, 2026. The same quote showed a GBp 2,203 to GBp 3,744 52-week range, keeping the home-market context separate from the euro reference price used by German investors.

The healthcare expansion adds a measurable operating angle to Experian's broader data and analytics strategy. For investors, the key question is whether new verification workflows can deepen provider relationships while the group continues serving financial, automotive, insurance and consumer markets. The stock stood at EUR 33.10 at Lang & Schwarz on October 15, 2026 at 1:15 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Experian stock.